drugset / Trial / NCT02361125
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to evaluate the effectiveness of ritalin (methylphenidate) taken on an as needed basis for the management of cancer related fatigue. The effects of methylphenidate on pain, mood, and sedation will be evaluated. Researchers will also evaluate the level of fatigue throughout the day and any possible causes of fatigue.
Timeline
- Start
- 2002-08-01
- Primary completion
- 2021-12-28
- Completion
- 2021-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 5 mg | Oral |
Indications
No indication recorded.